Document is current
Any future updates will be listed below
-
Authors
Khasawneh, Ashraf I.
Al Shboul, Sofian
Himsawi, Nisreen
Al Rousan, Amani
Shahin, Nisreen Abu
El-Sadoni, Mohammed
Alhesa, Ahmad
Abu Ghalioun, Ala’
Khawaldeh, Suzan
Shawish, Bayan
Mahfouz, Salem Abu
Al-Shayeb, Mais
Dawoud, Shatha Abo
Tlilan, Raghad
Nuseir, Mohammad
Alotaibi, Moureq R.
Abu Al Karsaneh, Ola
Asali, Fida
Mayordomo, Marcos Yébenes
Barham, Raghda
Khasawneh, Rame
Saleh, Tareq
-
Funding
Funding for this research was provided by:
Deanship of Scientific Research, King Saud University (RSPD2024R786)
Hashemite University (465/83/2019)
- License Information
-
More Information
Article History
Received: 3 June 2024
Accepted: 13 January 2025
First Online: 21 January 2025
Declarations
:
: All research activities under this work were conducted based on ethical approval obtained by Institutional Review Boards (IRB) at the Hashemite University (Protocol No. 11/9/2021/2022), JRMS (Protocol No. 10/2022/10), and PHH (Protocol No. HH/Research/5284) in accordance with the ethical standards as laid down in the Declaration of Helsinki. The requirement for informed consent was waived by the IRB at the primary institution of the principal investigator that approved the study (the Hashemite University) due to its nature that strictly includes the use of surplus tumor tissue samples. This waiver was further confirmed by the IRBs of the two clinical centers where samples were collected, namely, JRMS and PHH.
: Not applicable.
: The authors declare no competing interests.
